News Articles and Montana BioScience Alliance Newsletters
Billings Clinic is participating in a national trial to study the use of an advanced device to treat patients with atrial fibrillation who are at higher risk for stroke and we are enrolling participants now. Called the CHAMPION-AF trial and initiated by Boston Scientific, it is a randomized head-to-head trial designed to evaluate the safety and efficacy of the next-generation WATCHMAN FLX Left Atrial Appendage Closure Device within a broad population of patients with non-valvular atrial fibrillation (AF), including those who are […]
The NIA is accepting applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. Learn more about these open opportunities. The next deadline to apply is January 5, 2024, unless otherwise noted.
The Senate has voted to confirm President Joe Biden’s pick to run the National Institutes of Health (NIH), Dr. Monica Bertagnolli, filling the director spot at the country’s top medical research agency after a vacancy of almost two years.
Updates from product development and small business programs
Are you working to develop an innovative cancer technology? Take a step forward in your commercialization journey through the newly released FY2024 SBIR Contract Solicitation! This funding opportunity aims to provide early-stage funding to small businesses that are developing cancer technologies in areas defined by the National Cancer Institute.
The U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a confirmatory trial verified clinical benefit.